DYADIC INTERNATIONAL INC Increase (Decrease) in Income Taxes Payable
DYADIC INTERNATIONAL INC (DYAI) reported Increase (Decrease) in Income Taxes Payable of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-30.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable · last filed 2020-03-30
- DYADIC INTERNATIONAL INC increase (decrease) in income taxes payable for the quarter ending 2019-12-31 was $0.00, a 100.00% decline year-over-year.
- DYADIC INTERNATIONAL INC increase (decrease) in income taxes payable for the quarter ending 2019-09-30 was $0.00.
- DYADIC INTERNATIONAL INC increase (decrease) in income taxes payable for the quarter ending 2019-06-30 was $0.00.
- DYADIC INTERNATIONAL INC increase (decrease) in income taxes payable for the quarter ending 2019-03-31 was $0.00.
- DYADIC INTERNATIONAL INC increase (decrease) in income taxes payable for fiscal 2019 was $0.00.
- DYADIC INTERNATIONAL INC increase (decrease) in income taxes payable for fiscal 2018 was -$100.67K, a 203.74% decline from fiscal 2017.
- DYADIC INTERNATIONAL INC increase (decrease) in income taxes payable for fiscal 2017 was $97.04K.
| Period end | Increase (Decrease) in Income Taxes Payable 3 month | Increase (Decrease) in Income Taxes Payable 6 month | Increase (Decrease) in Income Taxes Payable 9 month | Increase (Decrease) in Income Taxes Payable 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $0.00 derived: sum of 2 quarters · filed 2020-03-30 | $0.00 derived: sum of 3 quarters · filed 2020-03-30 | $0.00 10-K · filed 2020-03-30 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $0.00 derived: sum of 2 quarters · filed 2019-11-13 | $0.00 10-Q · filed 2019-11-13 | $1.32K derived: sum of 4 quarters · filed 2020-03-30 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $0.00 10-Q · filed 2019-08-13 | $1.32K derived: sum of 3 quarters · filed 2020-03-30 | $1.32K derived: sum of 4 quarters · filed 2020-03-30 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-09 | $1.32K derived: sum of 2 quarters · filed 2020-03-30 | $1.32K derived: sum of 3 quarters · filed 2020-03-30 | $1.32K derived: sum of 4 quarters · filed 2020-03-30 |
| 2018-12-31 | $1.32K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $1.32K derived: sum of 2 quarters · filed 2020-03-30 | $1.32K derived: sum of 3 quarters · filed 2020-03-30 | -$100.67K 10-K · filed 2020-03-30 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $0.00 derived: sum of 2 quarters · filed 2019-11-13 | -$102.00K 10-Q · filed 2019-11-13 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | -$102.00K 10-Q · filed 2019-08-13 | ||
| 2018-03-31 | -$102.00K 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | $97.04K 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |